The Yuan requests your support! Our content will now be available free of charge for all registered subscribers, consistent with our mission to make AI a human commons accessible to all. We are therefore requesting donations from our readers so we may continue bringing you insightful reportage of this awesome technology that is sweeping the world. Donate now
A viable path out of the pandemic is crucial
By William A. Haseltine  |  Apr 05, 2023
A viable path out of the pandemic is crucial
Image courtesy of and under license from
Most people now act as if COVID-19 is over, yet the virus remains active and dangerous. The limited ability of current vaccines and drugs to prevent infection or treat long-COVID means much more must be done before the threat posed by this pathogen is truly a thing of the past.

FAIRFIELD COUNTY, CONNECTICUT – Three years have passed since the dark days of early 2020, and the world has made extraordinary progress in the fight against the COVID-19 pandemic. Yet in many ways, the world is now back to square one. Public-health precautions that were ramped up from 2020 to 2022 are now virtually nonexistent in most parts of the world, and the currently available vaccines and drugs neither prevent infections nor - for broad swaths of the population - even effectively treat them.

Make no mistake: COVID-19 still poses a clear and present danger. Research shows that two or more COVID-19 re-infections doubles the risk of negative health outcomes such as death, blood clots, and lung damage. The risk of cardiovascular events has been found to increase by 4.5 percent for up to 12 months after an infection, regardless of age, race, sex, obesity, smoking, or other factors.

Nearly one in five Americans are reporting ongoing long-COVID symptoms, and recent research estimates that as many as 4 million people suffering from this condition are unable to work. The long-term social and economic impact of these continual re-infections is still unknown but should not be underestimated.

To be clear, the messenger RNA vaccines in particular have done an excellent job of reducing hospitalizations and deaths, but questions remain regarding waning immunity. Meanwhile, public uptake has decreased with each new booster: A mere

The content herein is subject to copyright by Project Syndicate. All rights reserved. The content of the services is owned or licensed to The Yuan. The copying or storing of any content for anything other than personal use is expressly prohibited without prior written permission from The Yuan, or the copyright holder identified in the copyright notice contained in the content.
Share your thoughts.
The Yuan wants to hear your voice. We welcome your on-topic commentary, critique, and expertise. All comments are moderated for civility.